Neurocritical Care News

CHICAGO – Rates of reaction times were slower among individuals who had long COVID compared with healthy counterparts, a researcher showed in a poster presentation at the 2022 American Neurological Association meeting.

CHICAGO – An app-based cognitive assessment tool set baseline scores for college football players and may be useful in rapid sideline concussion diagnosis, according to a poster at the 2022 American Neurological Association meeting.

A team of Penn State University researchers has been awarded a $1.2 million grant from the NIH to develop a machine learning system for the early detection of Alzheimer’s disease.

CHICAGO — Stephen Reich, MD, professor of neurology at the University of Maryland School of Medicine in Baltimore, spoke at ANA 2022 about clinical features of functional movement disorders and how to best identify them.

CHICAGO — Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022.

CHICAGO — Nicole Rosendale, MD, assistant professor of neurology at the University of California, San Francisco, discusses highlights from her talk at ANA 2022 on equity in neurologic care for the LGBTQ+ community.

CHICAGO – Jennifer A. Frontera, MD, professor of neurology at NYU School of Medicine, discussed possible therapeutic strategies for those with long COVID who are experiencing neurological symptoms at ANA 2022.

CHICAGO — The neurological pathology of COVID-19 becomes more complex as symptoms persist and tends to affect the central nervous system more prominently, according to an expert at the American Neurological Association annual meeting.

CHICAGO – Felicia Chow, MD, MAS, a neuro-infectious specialist at the University of California, San Francisco, discussed the care and approach to neurological infections during a panel at ANA 2022.

CHICAGO – Ray Dorsey, MD, MBA, neurology professor at the University of Rochester, discusses a presentation he gave on environmental risk factors that may be associated with Parkinson’s disease at ANA 2022.